Menu

Gene Activity Could Give Clues to Time of Death

RNA-sequencing data reveal that specific tissues have distinct changes in gene expression after an individual has passed away.

Feb 12, 2018
Ashley Yeager

ISTOCK, SOUTH_AGENCYResearchers have identified specific gene activity patterns that appear in human tissue shortly after death. These findings, reported today (February 13) in Nature Communications, could one day help crime-scene investigators pinpoint time of death and improve forensic analysis.

By examining gene activity in 36 different postmortem human tissues, Roderic Guigó, a computational biologist at the Centre for Genomic Regulation in Barcelona, and his colleagues found patterns in the way gene expression increased or decreased with time.

“The response to the death of the organism is quite tissue specific,” Guigó tells Science. He explains that muscle genes had swift boosts or drops in activity, while gene activity in the brain and spleen didn’t change much with time. Guigó and his colleagues also observed that the majority of the changes occurred 7 to 14 hours after death. After that, the transcriptome “seems to stabilize,” the researchers write in the paper.

The findings make sense, Ilias Tagkopoulos, a computer scientist at the University of California, Davis who was not involved with the work, tells Science. “At a cellular level, death is a cascade of events affecting biological processes at different timescales,” he says, and genes control that cascade.

Based on the gene activity patterns, the team developed computational models to predict time of death. The researchers designed algorithms to learn gene activity patterns from 399 individuals, then tested them to see how well they predicted the time of death of 129 others. These were proof-of-concept models, the authors say, but they are now working on making them more useful in forensic cases.

Currently, medical examiners use body temperature, changes in skin color, and rigor mortis to determine when a person has died. Rigor mortis and body discoloration work fairly well as early indicators, but they are only really “good for perhaps some very gross estimates, like a few hours or a day or so,” Carolyn Rando, a lecturer in bioarchaeology and forensic anthropology at University College London tells The Times. The article notes that gene activity might be good at pinpointing time of death in the first 24 hours.

In addition to holding information about time of death, Guigó tells Science, “changes in gene expression may also carry the signatures of the cause of death.”

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.